Senior Manager of Reporting & SOX, COMPASS Pathways
$126-154k
Plus additional discretionary bonuses and equity
More information about location
Biotech accelerating patient access to evidence-based innovation in mental health
Be an early applicant
Biotech accelerating patient access to evidence-based innovation in mental health
201-500 employees
Be an early applicant
$126-154k
Plus additional discretionary bonuses and equity
More information about location
201-500 employees
Company mission
To accelerate patient access and experience to evidence-based innovation in mental health care, to achieve a vision of a world of mental wellbeing.
Role
Who you are
- The role requires flexibility, a strong attention to detail, and a passion for collaborative, cross-functional work, with increasing interaction with the Executive Team as the company moves toward commercialization
- The successful candidate will likely have a strong academic background, with a proven track-record of working on US listed companies and an entrepreneurial outlook
- CPA qualified – Big 4 accounting experience preferred
- High quality academic background
- Operates as a self-starter and can work independently
- Attentive to detail, data integrity and accuracy
- Fast paced, ambitious, independent and with a strong work ethic
- Able to interact with colleagues across the business
- Committed to Compass’ ethos and values
- Biotech and US-listed company experience strongly preferred
What the job involves
- The Senior Manager, Reporting & SOX will support the Director, External Reporting (based East Coast, US) and the rest of the Finance team (hybrid US & UK) and play an integral part in ongoing SEC Reporting (including external audit review) as well as SOX compliance including process design and monitoring
- On an annual basis, this role will support the UK Statutory Accounts process
- The majority of this role will involve contributing to SEC reporting efforts and leading process design, refinement and documentation efforts for expanding business processes, in particular as we progress through commercialization
- This role will spearhead process improvement initiatives, including the documentation and assessment of related controls to a SOX standard. Currently, the Company reports under SOX 404(a) and expects to be in scope for 404(b) by FY27. The annual UK statutory accounts are prepared under IFRS
- The Company uses NetSuite as its ERP system, Fidelity as its share administration platform, Workday Adaptive for budgeting and partners with ADP as payroll providers. We use Workiva/Wdesk to support SOX documentation efforts
- This is an exceptional opportunity to join a growing, well-funded international biotech company. You will be working with highly experienced Leadership and Executive teams
- Reports to: Director, External Reporting
- Working closely with the Senior Director, Controller and Director of External Reporting on quarterly and annual reporting processes including interactions with external audit
- Proactive collaboration with other members of the Finance function and the wider company. We encourage cross-functional working and support those who wish to gain experience beyond their immediate job description
- Preparation of technical accounting memos as required
- Working closely with external tax advisors
- Lead SOX process design, documentation, and monitoring (currently 404(a); anticipating 404(b))
- Cross-functional collaboration to ensure accurate documentation and controls for evolution of processes
- Support of internal audit program and partnering with our external partner (RSM), to ensure the controls which they operate are appropriately evidenced
- Working closely with the Finance team and cross-functionally with IT, Legal, HR and Commercial teams, in particular, to ensure processes are accurately documented and appropriate controls are designed with consideration of both best practices and supporting scalability
Our take
There’s been a major movement towards treating mental health issues with psychedelics over the last few years. While the vast majority of this work is still in R&D and clinical trials, the space has become awash with capital investment, with a handful of companies even going public.
COMPASS Pathways is one of those to go public, along with MindMed in 2020. The company is developing methods for treating depression and other mental health issues with psilocybin – the naturally occurring psychedelic chemical found in mushrooms.
The growth of COMPASS from being founded in 2016 to IPO in 2020 has been extraordinary. There have been a few ups and downs since then (as is the case with most PLCs), with each rise and fall dependent on the progress of its trials. However, the fact that the company recently appointed former Otsuka Pharmaceutical executive Kabir Nath as CEO, bolstered by $285 million in private placement VC shows that it's determined to stay ahead of the competition.
Freddie
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 3 rounds)
Apr 2020
$80m
SERIES B
Oct 2018
$25m
SERIES A
Total funding: $109.1m
Company benefits
- Pension and retirement savings plans
- Flexible working arrangements, including flexible hours, working-from-home and hybrid working
- Community Circles: a regular opportunity for team members to connect, share lived experiences, inspire others, and learn from each other
- Regular virtual and in-person social events, including a London-based hiking group, art and creative workshops, food and drinks evenings, team picnics, and holiday celebrations
- Comprehensive and market-leading health and wellness benefits including company paid healthcare plans
- Confidential counselling or therapy sessions via our Employee Assistance Programme
- Support from our own dedicated Community Wellbeing Lead to guide team members to our resources
- Workplace wellbeing initiatives, including employee-led yoga, meditation, mindfulness, and support groups for parents and carers and for people who are neurodiverse
- Breast-feeding facilities at our London office
- Wellbeing Leadership Forums for Line Managers
- Generous paid time off/annual leave allowance including one company closing per year and your birthday off
- Generous paid parental leave for eligible team members, up to 39 weeks
- Paid family and dependent care leave in addition to parental leave
- Job architecture, providing employees with guidance and clear pathways for developing and progressing their career and twice-yearly promotions cycle
- A process for performance and development goals that is tied to employees receiving feedback throughout the year and assessing individual performance and rewards at the end of the year
- Dedicated internal resources including regular webinars to support employees’ personal development and career goals
- A learning curriculum of courses on offer delivered by external experts to develop specific skill areas
- Dedicated effort for early career team members to learn skills and strategies for advancement
Company HQ
Soho, London, UK
Leadership
Kabir Nath
(CEO)Joined as CEO in 2022, having served as Senior Managing Director of Global Pharmaceutical Business at Japanese company Otsuka. Prior to this, they spent a decade at Bristol Myers Squibb in a number of roles including SVP of Virology, US Pharmaceuticals.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 2 more jobs at COMPASS Pathways